1. Home
  2. WDFC vs DNLI Comparison

WDFC vs DNLI Comparison

Compare WDFC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$201.98

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$20.22

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
DNLI
Founded
1953
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
WDFC
DNLI
Price
$201.98
$20.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
14
Target Price
$270.00
$34.33
AVG Volume (30 Days)
108.8K
1.6M
Earning Date
04-09-2026
05-06-2026
Dividend Yield
1.91%
N/A
EPS Growth
30.92
N/A
EPS
2.78
N/A
Revenue
$488,109,000.00
N/A
Revenue This Year
$8.23
N/A
Revenue Next Year
$5.85
$408.85
P/E Ratio
$71.42
N/A
Revenue Growth
19.49
N/A
52 Week Low
$175.38
$12.58
52 Week High
$253.24
$23.77

Technical Indicators

Market Signals
Indicator
WDFC
DNLI
Relative Strength Index (RSI) 45.23 53.72
Support Level $199.17 $18.27
Resistance Level $212.22 $20.40
Average True Range (ATR) 5.95 0.92
MACD -0.12 0.10
Stochastic Oscillator 49.29 71.47

Price Performance

Historical Comparison
WDFC
DNLI

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: